| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/21/2006 | WO2006098978A1 Diagnostics method for identifying candidate patients for the treatment with trastuzumab |
| 09/21/2006 | WO2006098952A2 Corn event 3272 and methods of detection thereof |
| 09/21/2006 | WO2006098612A1 Method for determining an allergic response |
| 09/21/2006 | WO2006098582A1 Primer for detection of human papillomavirus |
| 09/21/2006 | WO2006098520A1 Screening method |
| 09/21/2006 | WO2006098488A1 Method of ameliorating symptom caused by mood disturbance |
| 09/21/2006 | WO2006098485A1 Glutamate decarboxylase mutant |
| 09/21/2006 | WO2006098435A1 Detecting chip and method of detecting substance using the same |
| 09/21/2006 | WO2006098428A1 Method of lessening nonspecific amplification from primer dimer |
| 09/21/2006 | WO2006098401A1 Method for determination of risk of rheumatoid arthritis |
| 09/21/2006 | WO2006098340A1 Molybdenum transporter and gene thereof |
| 09/21/2006 | WO2006098049A1 Gene detection method and gene detection kit utilizing photosensitization reduction reaction |
| 09/21/2006 | WO2006097787A1 Bovine cast gene snp and meat tenderness |
| 09/21/2006 | WO2006097748A2 Peptide stabilizer compounds and screening method |
| 09/21/2006 | WO2006097723A1 Detection method for ljungan virus |
| 09/21/2006 | WO2006097636A1 Nucleic acid fragments and specific detection method by molecular identification of different bacteria species of the genus acinetobacter |
| 09/21/2006 | WO2006097631A1 Method and device for isolating micro-organisms |
| 09/21/2006 | WO2006097549A1 Dna analysis-based method for the identification of species of partridge and the detection of hybrids of the genus alectoris |
| 09/21/2006 | WO2006097463A2 Compositions and methods for treating and diagnosing inflammatory disorders |
| 09/21/2006 | WO2006097462A2 Compositions and methods for treating inflammatory cns disorders |
| 09/21/2006 | WO2006097388A2 Nucleic acid variants in the c1qr1 gene associated with altered innate immunity. |
| 09/21/2006 | WO2006097346A1 Method of predicting the clinical response to platinum based chemotherapeutic treatment |
| 09/21/2006 | WO2006097339A2 Method and materials therefor |
| 09/21/2006 | WO2006097288A1 Nutritional compositions for modulating vitamin c bio-availability |
| 09/21/2006 | WO2006097284A1 Variants of hepatitis b virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof |
| 09/21/2006 | WO2006097233A2 Determination of antibiotic resistance in staphylococcus aureus |
| 09/21/2006 | WO2006097051A1 Markers for prenatal diagnosis and monitoring |
| 09/21/2006 | WO2006097049A1 A method for the detection of chromosomal aneuploidies |
| 09/21/2006 | WO2006096988A1 Method for characterizing cell surface charge |
| 09/21/2006 | WO2006096985A1 Human endogenous retrovirus with foamy-like properties and uses thereof |
| 09/21/2006 | WO2006096926A1 Method of land management involving microbial bioassay. |
| 09/21/2006 | WO2006084018A3 Methods for determining responsiveness to cancer therapy |
| 09/21/2006 | WO2006077241A3 Kringle domains in a calcium sensor fusion protein |
| 09/21/2006 | WO2006073472A3 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples |
| 09/21/2006 | WO2006063462A9 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 09/21/2006 | WO2006062882A9 Protein-protein interaction detection system using fluorescent protein microdomains |
| 09/21/2006 | WO2006059125A3 Tumour suppressor genes |
| 09/21/2006 | WO2006050237A3 Method and compositions for determining resistance of susceptibility of hiv-1 to stavudine |
| 09/21/2006 | WO2006048265A3 Classifying leukemia with translocation (9;22) |
| 09/21/2006 | WO2006048264A3 Gene expression profiling in acute lymphoblastic leukemia (all), biphenotypic acute leukemia (bal), and acute myeloid leukemia (aml) m0 |
| 09/21/2006 | WO2006047412A3 Methods and kits for detecting germ cell genomic instability |
| 09/21/2006 | WO2006043182A3 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 09/21/2006 | WO2006042303A3 Methods and compositions for analyzing ribonucleic acids |
| 09/21/2006 | WO2006041995A3 Compositions and methods comprising biological samples for quality controls |
| 09/21/2006 | WO2006041472A3 Enzyme-based device for environmental monitoring |
| 09/21/2006 | WO2006040373B1 Identification of dna in raw or processed foods and compound feeds |
| 09/21/2006 | WO2006031800A3 Reverse transfection of cell arrays |
| 09/21/2006 | WO2006028517A3 Comparative genomic resequencing |
| 09/21/2006 | WO2006027206A3 In vitro method for the diagnosis of acute leukaemia |
| 09/21/2006 | WO2006026654A3 Method for detecting a recombinant event |
| 09/21/2006 | WO2006012393A3 Addition of transgenes into adenoviral vectors |
| 09/21/2006 | WO2005112988B1 Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1) |
| 09/21/2006 | WO2005111240A3 Field-switch sequencing |
| 09/21/2006 | WO2005098424A8 Method and apparatus for implementing threshold based correction functions for biosensors |
| 09/21/2006 | WO2005066638A8 Analytical instrument having improved arrangement of reagent section and analytical method |
| 09/21/2006 | WO2005059096A3 Methods for high fidelity production of long nucleic acid molecules with error control |
| 09/21/2006 | WO2005049849A3 Fluorescence quenching azo dyes, their methods of preparation and use |
| 09/21/2006 | WO2005047308A3 Peptide-based diagnostic reagents for sars |
| 09/21/2006 | WO2005037053A3 High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens |
| 09/21/2006 | WO2005033271A3 METHODS OF RAPID DETECTION AND IDENTIFICATION OF BIOAGENTS USING microRNA |
| 09/21/2006 | WO2005027714A3 Sensitive and rapid biodetection |
| 09/21/2006 | WO2005001057A3 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 09/21/2006 | WO2004110386A3 Molecular interaction sites of coronavirus rna and methods of modulating the same |
| 09/21/2006 | WO2004108946A3 Crystals of herpes simplex virus 1 dna polymerase and/or herpes simplex virus 1 dna polymerase-like proteins and the use thereof |
| 09/21/2006 | WO2004099380A3 Method for identifying matched groups |
| 09/21/2006 | WO2004094616A3 Silencing transcription by methylation |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | WO2002050303A3 Protein-protein interactions |
| 09/21/2006 | US20060212956 Animal model of ligand activated HER2 expressing tumors |
| 09/21/2006 | US20060212953 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 09/21/2006 | US20060212229 Method and system for providing a probe array chip design database |
| 09/21/2006 | US20060211774 Method of diagnosins a genetic susceptibility for bone damage |
| 09/21/2006 | US20060211684 Use of alpha-2 adrenergic receptor agonists |
| 09/21/2006 | US20060211673 Modulation of neurodegenerative diseases through the estrogen receptor |
| 09/21/2006 | US20060211647 Binding proteins comprising transduction domain operably linked to targeting signal peptide comprising high mobility group boxes; for treatment of mitochondrial diseases |
| 09/21/2006 | US20060211645 Modulation of neurodegenerative diseases |
| 09/21/2006 | US20060211641 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 09/21/2006 | US20060211624 Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies |
| 09/21/2006 | US20060211622 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 09/21/2006 | US20060211618 Polynucleotides and polypeptides of the erythropoietin gene |
| 09/21/2006 | US20060211604 Methods for treating inflammatory disorders using regulators of microvessel dilations |
| 09/21/2006 | US20060211150 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211149 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211143 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211142 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance |
| 09/21/2006 | US20060211134 Priming module for microfluidic chips |
| 09/21/2006 | US20060211108 Methods and compositions for impairing multiplication of HIV-1 |
| 09/21/2006 | US20060211091 MAGE-A3 peptides presented by HLA class II molecules |
| 09/21/2006 | US20060211090 Human cDNAs and proteins and uses thereof |
| 09/21/2006 | US20060211082 Methods and compositions for rapidly detecting and quantifying viable Legionella |
| 09/21/2006 | US20060211081 Sec14 as an antifungal target |
| 09/21/2006 | US20060211080 Automated biological plate spreader |
| 09/21/2006 | US20060211079 Systemic markers for asthma and analogous diseases |
| 09/21/2006 | US20060211078 Identifying enzyme modulators for treating neurodegenerative, autoimmune and tumor diseases |
| 09/21/2006 | US20060211077 Methods and compositions to diagnose disease using concatenated oligopeptide standard |
| 09/21/2006 | US20060211076 Method and device for the qualitative and/or quantitative determination of a protein and/or peptide pattern of a fluid sample, which has been taken from a human or animal body |
| 09/21/2006 | US20060211075 Enzyme sensors including environmentally sensitive or fluorescent labels and uses thereof |
| 09/21/2006 | US20060211074 Kinase-directed, activity-based probes |
| 09/21/2006 | US20060211073 Assay for B-Raf activity based on intrinsic MEK ATPase activity |
| 09/21/2006 | US20060211072 Process, composition and kit for providing a stable whole blood calibrator/control |